ENDONOVO THERAPEUTICS, INC.: 10-Q filed 2016-11-14

Name: ENDONOVO THERAPEUTICS, INC.: 10-Q filed 2016-11-14
Creator: ENDONOVO THERAPEUTICS, INC.

What ENDONOVO THERAPEUTICS, INC. reported in its quarterly report filed 2016-11-14 (fiscal Q3 2016): 24 published measures, 56 facts as tagged in accession 0001493152-16-014851.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-11-14
Fiscal period: fiscal Q3 2016
Accession: 0001493152-16-014851 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ENDONOVO THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-09-30	264,456	USD
At 2015-12-31	409,363	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-09-30	8,783,384	USD
At 2015-12-31	9,685,423	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2016-09-30	-8,518,928	USD
At 2015-12-31	-9,276,060	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-09-30	94,675	USD
At 2015-12-31	41,473	USD
At 2015-09-30	27,479	USD
At 2014-12-31	988	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-2,218,841	USD	92
2016-01-01 to 2016-09-30	-4,575,841	USD	274
2015-07-01 to 2015-09-30	-1,281,037	USD	92
2015-01-01 to 2015-09-30	-2,238,690	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	-1,803,684	USD	274
2015-01-01 to 2015-09-30	-808,045	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	1,856,886	USD	274
2015-01-01 to 2015-09-30	834,536	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-09-30	-17,634,452	USD
At 2015-12-31	-13,058,611	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-09-30	19,781	USD
At 2015-12-31	31,657	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-1,310,748	USD	92
2016-01-01 to 2016-09-30	-4,778,109	USD	274
2015-07-01 to 2015-09-30	-469,875	USD	92
2015-01-01 to 2015-09-30	-1,314,967	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-09-30	244,675	USD
At 2015-12-31	377,706	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-09-30	8,288,771	USD
At 2015-12-31	9,486,153	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	1,310,748	USD	92
2016-01-01 to 2016-09-30	4,778,109	USD	274
2015-07-01 to 2015-09-30	469,475	USD	92
2015-01-01 to 2015-09-30	1,317,070	USD	273

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-400	USD	92
2015-01-01 to 2015-09-30	2,103	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-09-30	124,766,871	shares
At 2015-12-31	104,803,401	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2016-09-30	9,104,619	USD
At 2015-12-31	3,773,642	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2016-09-30	1,878,462	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2016-09-30	78,232	USD
At 2015-12-31	78,232	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2016-09-30	-58,451	USD
At 2015-12-31	-46,575	USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	11,876	USD	274
2015-01-01 to 2015-09-30	10,920	USD	273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	11,876	USD	274
2015-01-01 to 2015-09-30	10,920	USD	273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-908,093	USD	92
2016-01-01 to 2016-09-30	202,268	USD	274
2015-07-01 to 2015-09-30	-811,162	USD	92
2015-01-01 to 2015-09-30	-923,723	USD	273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	500	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	1,055,829	USD	274
2015-01-01 to 2015-09-30	81,960	USD	273

Inspect the source

Entity: ENDONOVO THERAPEUTICS, INC. / CIK 0001528172
Captured: 2026-09-20T09:15:36.026Z
SEC response SHA-256: 77af3f2eba134146bbd094e17b18f0fd658f8dd873b389b6434b1de9b2ac5f8a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001528172.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))